Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients

被引:18
作者
Guglielmo, BJ [1 ]
Quan, LA [1 ]
Stulbarg, MS [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,ADULT CYST FIBROSIS CTR,SAN FRANCISCO,CA 94143
关键词
D O I
10.1093/jac/37.5.1040
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1040 / 1042
页数:3
相关论文
共 6 条
[1]   ANTIBIOTIC PHARMACOKINETICS IN CYSTIC-FIBROSIS - DIFFERENCES AND CLINICAL-SIGNIFICANCE [J].
DEGROOT, R ;
SMITH, AL .
CLINICAL PHARMACOKINETICS, 1987, 13 (04) :228-253
[2]  
Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17
[3]  
MATTHEWS Z, 1994, AUST NZ J MED, V24, P730, DOI 10.1111/j.1445-5994.1994.tb01796.x
[4]   ONCE-DAILY VS CONTINUOUS AMINOGLYCOSIDE DOSING - EFFICACY AND TOXICITY IN ANIMAL AND CLINICAL-STUDIES OF GENTAMICIN, NETILMICIN, AND TOBRAMYCIN [J].
POWELL, SH ;
THOMPSON, WL ;
LUTHE, MA ;
STERN, RC ;
GROSSNIKLAUS, DA ;
BLOXHAM, DD ;
GRODEN, DL ;
JACOBS, MR ;
DISCENNA, AO ;
CASH, HA ;
KLINGER, JD .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) :918-932
[5]  
PRESTON SL, 1995, PHARMACOTHERAPY, V15, P297
[6]   EVALUATION OF A ONCE-DAILY NETILMICIN REGIMEN IN THE TREATMENT OF CYSTIC-FIBROSIS [J].
SMITH, DL ;
STABLEFORTH, DE ;
GEDDES, AM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (01) :191-193